论文部分内容阅读
美洛西林(mezlocillin,MZPC)为新型合成的第4代青霉素,抗菌谱广,对绿脓杆菌有效[1],已在国外应用多年,近年在我国应用。本文对42例下呼吸道感染患者给予美洛西林治疗并与头孢拉啶及头孢呋肟进行对照,旨在进一步阐明其疗效。1 对象与方法1.1 病例选择 选自我院1998年1月至199
Mezlocillin (MZPC) is a new type of 4th generation penicillin which has wide antibacterial spectrum and is effective against Pseudomonas aeruginosa [1]. It has been used abroad for many years and has been applied in China in recent years. In this paper, 42 patients with lower respiratory tract infection were treated with mezlocillin and compared with cefradine and cefuroxime in order to further clarify its efficacy. 1 objects and methods 1.1 cases selected from our hospital from January 1998 to 199